Location History:
- Monvrovia, MD (US) (1997)
- Monrovia, MD (US) (1998)
Company Filing History:
2 out of 1,217 
2 out of 9 Years Active: 1997-1998
Title: The Innovative Contributions of Jeffrey G. Supko
Introduction
Jeffrey G. Supko is a notable inventor based in Monrovia, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of new pharmaceutical compounds. With a total of 2 patents to his name, Supko's work has the potential to impact the lives of many patients.
Latest Patents
Supko's latest patents focus on Brefeldin A derivatives and their utility in the treatment of cancer. These derivatives are characterized by a specific formula wherein one of the substituents is hydrogen, while the other contains a substituent group with 1 to 12 carbon atoms, which includes a basic nitrogen atom or a quaternary ammonium group. These compounds exhibit promising antitumor activity and can be administered to human patients without the complications associated with traditional Brefeldin A.
Career Highlights
Throughout his career, Supko has worked with various organizations, including the United States of America as represented by the Department of Health and Starks Associates Inc. His work has been instrumental in advancing cancer treatment methodologies and improving patient outcomes.
Collaborations
Supko has collaborated with notable professionals in his field, including Louis Malspeis and B Rao Vishnuvajjala. These collaborations have further enriched his research and contributed to the development of effective cancer therapies.
Conclusion
Jeffrey G. Supko's innovative work in the development of Brefeldin A derivatives showcases his commitment to advancing cancer treatment. His contributions are significant and hold promise for future medical applications.